Navigation Links
Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
Date:5/23/2013

SOUTH EASTON, Mass., May 23, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First Quarter 2013 financial results and to provide a business update. The teleconference information is provided below:

Date: Thursday, May 23, 2013
Time: 11:00 a.m. Eastern Daylight Time (EDT)

Dial-in: (800) 875-3456 (U.S.); (800) 648-0973 (Canada); (302) 607-2001 (Int'l)
Passcode: VS22823

For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call and will be accessible through the Company's website.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT"). PCT is a patented, enabling technology platform with multiple applications in the estimated $6 billion life sciences sample preparation market. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. PBI currently focuses its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for mass spectrometry, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, forensics, histology, and counter-bioterror applications.

For more information about PBI and this press release, please click on the following link:
http://www.pressurebiosciences.com




Investor Contacts:

Richard T. Schumacher, President & CEO

Pressure BioSciences, Inc.

Conrad Mir, CFO

(T) 508-230-1828


'/>"/>
SOURCE Pressure BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. High pressure gold nanocrystal structure revealed
2. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
3. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
4. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
5. Pressure BioSciences, Inc. Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand
6. Pressure BioSciences, Inc. Reaches Agreement with Investors on Initial $600,000 Tranche of $1.2 Million Above-Market Private Placement; Proceeds to Support Continued Commercialization of PCT Product Platform
7. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
8. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
9. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
10. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
11. The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2019)... YORK (PRWEB) , ... May 22, 2019 , ... ... has closed a $8 million Series A funding round co-led by Astanor Ventures ... Empire State Development Fund and iSelect Fund . The company has ...
(Date:5/14/2019)... ... May 14, 2019 , ... Gateway Genomics , a leading ... space from 2,500 to 5,000 square feet. , “This past year has seen ... says Gateway Genomics CEO, Chris Jacob. “The SneakPeek At-Home test, which is mailed directly ...
(Date:5/2/2019)... ... April 30, 2019 , ... ... REPROCELL USA Inc. has demonstrated its ability to provide various services and ... to enhance customer satisfaction through the effective implementation of its quality management ...
(Date:4/25/2019)... ... ... is an albino, deaf Great Dane. His owners rescued him when he was four months ... his hearing impairment, he was always an active and playful pup. Frank bonded with his ... As the two grew, playtime became rougher and Frank ended up injuring his right rear ...
Breaking Biology Technology:
(Date:6/6/2019)... CITY (PRWEB) , ... June 05, 2019 , ... ... packaging, announces the opening of a new network station and service center in ... — and 12th in the world — with more than $1.75 billion in ...
(Date:6/4/2019)... ... June 04, 2019 , ... Harper was three years old ... revealed severe elbow dysplasia, which caused painful osteoarthritis in the joints. She was ... parents were heartbroken. , The surgical specialist, Dr. Christopher Eich of Southern California ...
(Date:6/1/2019)... ... May 31, 2019 , ... The University of Vermont ... in BioFactura’s $6M Series B Financing Round. , “With the commitment from ... bring significant financial and business resources to bear as we advance our biopharmaceutical ...
Breaking Biology News(10 mins):